[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352547-105":59,"doc-detail-352547-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","vstm2l-mediates-the-release-of-extracellular-vimentin-to-drive-lymph-node-metastasis-in-gastric-cancer","VSTM2L mediates the release of extracellular vimentin to drive lymph node metastasis in gastric cancer","","Background: Lymph node metastasis (LNM) is the most common dissemination route of gastric cancer (GC) and its mechanisms remain poorly understood. This study investigates V-Set and Transmembrane Domain Containing 2 Like (VSTM2L) in GC LNM. Methods: VSTM2L expression was assessed by immunohistochemistry, qPCR, and western blot, and effects on proliferation, invasion, lymphangiogenesis, and metastasis were tested with multiple in vitro and in vivo assays. Protein interactions and vimentin secretion were analyzed by immunoprecipitation and ELISA, with functional rescue experiments. Results: VSTM2L is upregulated, correlates with poor survival, and promotes tumor aggressiveness via extracellular vimentin secretion and VEGFR-3 signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/vstm2l-mediates-the-release-of-extracellular-vimentin-to-drive-lymph-node-metastasis-in-gastric-cancer/352547/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/vstm2l-mediates-the-release-of-extracellular-vimentin-to-drive-lymph-node-metastasis-in-gastric-cancer/352547.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does VSTM2L play in gastric cancer lymph node metastasis?","Question",{"text":112,"@type":113},"VSTM2L is upregulated in GC and lymph node-positive tissues and promotes lymphangiogenesis and metastasis, functioning as a driver of LNM.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was VSTM2L expression and function evaluated in this study?",{"text":117,"@type":113},"Expression was measured by immunohistochemistry, qPCR, and western blot, while effects on proliferation, invasion, lymphangiogenesis, and metastasis were tested using colony formation, Transwell, tube formation, and in vivo experiments.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links VSTM2L to extracellular vimentin and lymphangiogenesis?",{"text":121,"@type":113},"VSTM2L interacts with vimentin to enhance intracellular stability and promote extracellular secretion; released vimentin then increases focal adhesion complex proteins and activates VEGFR-3 signaling in lymphatic endothelial cells, leading to cytoskeletal rearrangement and lymphangiogenesis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352547,1790939740,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Wu et al. Biology Direct (2026) 21:29 [https://doi.org/10.1186/s13062-026-00754-y](https://doi.org/10.1186/s13062-026-00754-y)  \nBiology Direct  \nRESEARCH Open Access  \nVSTM2L mediates the release of extracellular vimentin to drive lymph node metastasis in gastric cancer  \nLuyao Wu1†, Hao Fan2†, Huaiming Sang3†, Xinyu Zhao4, Yuan Li4 and Jian Xiao1*  \nAbstract  \nBackground Lymph node metastasis (LNM), the most common route of gastric cancer (GC) dissemination, remains poorly understood. This study aimed to elucidate the role ofV-Set and Transmembrane Domain Containing 2 Like (VSTM2L) in GC LNM.  \nMethods VSTM2L expression was evaluated by immunohistochemistry, qPCR, and western blot. Its effects on cell proliferation, invasion, lymphangiogenesis, and metastasis were examined via colony formation, Transwell, tube formation, and in vivo experiments, respectively. Protein interactions were analyzed by immunoprecipitation and GST-pull down. The role ofVSTM2L in promoting vimentin secretion was assessed using Ponceau Red staining and Enzyme-Linked Immunosorbent Assay (ELISA) . Rescue experiments were conducted to confirm the functional significance of vimentin.  \nResults VSTM2L was significantly upregulated in GC cell lines and lymph node-positive tissues, and its high expression correlated with poor survival. Loss-and gain-of-function experiments demonstrated that VSTM2L promotes GC cell proliferation, invasion, and lymphangiogenesis. Mechanistically, VSTM2L interacted with vimentinto enhance its intracellular stability and promote its extracellular secretion. The released vimentin subsequently upregulated focal adhesion complex proteins intracellularly and activated Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) signaling in human lymphatic endothelial cells, leading to cytoskeletal rearrangement and lymphangiogenesis, respectively. Consistent with this mechanism, both in vitro and in vivo evidence confirmed that the secretion of vimentin is essential for the pro-lymphangiogenic effects of VSTM2L.  \nConclusions We identify VSTM2L as a novel and potent driver of LNM. Our findings highlight the therapeutic potential of targeting the VSTM2L-extracellular vimentin axis in GC and elucidate a previously unrecognized mechanism driving vimentin secretion and lymphatic metastasis.  \nKeywords V-set and transmembrane domain containing 2 like, Vimentin, Vascular endothelial growth factor receptor-3, Lymph node metastasis, Gastric cancer  \n†Luyao Wu, Hao Fan and Huaiming Sang contributed equally to this work.  \n*Correspondence: Jian Xiao [xjmed2018@163.com](xjmed2018@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nIntroduction  \nGastric cancer (GC) is one of the most prevalent and lethal malignant tumors within the digestive system [1]. While chemoradiotherapy, surgery, and ","cbCaikouxMPTkWqA","https://ap.wps.com/l/cbCaikouxMPTkWqA","pdf",13045647,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What role does VSTM2L play in gastric cancer lymph node metastasis?\",\"answer\":\"VSTM2L is upregulated in GC and lymph node-positive tissues and promotes lymphangiogenesis and metastasis, functioning as a driver of LNM.\"},{\"question\":\"How was VSTM2L expression and function evaluated in this study?\",\"answer\":\"Expression was measured by immunohistochemistry, qPCR, and western blot, while effects on proliferation, invasion, lymphangiogenesis, and metastasis were tested using colony formation, Transwell, tube formation, and in vivo experiments.\"},{\"question\":\"What mechanism links VSTM2L to extracellular vimentin and lymphangiogenesis?\",\"answer\":\"VSTM2L interacts with vimentin to enhance intracellular stability and promote extracellular secretion; released vimentin then increases focal adhesion complex proteins and activates VEGFR-3 signaling in lymphatic endothelial cells, leading to cytoskeletal rearrangement and lymphangiogenesis.\"}]","VSTM2L mediates the release of extracellular vimentin to drive lymph node metastasis in gastric cancer | PDF",1790100212,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7004139234712259910ff2651178ed2.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8368ae077ec20010e21be2a46d3d391c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c69078e28aeb6696fc30c8587858d67b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56814b5cb21711aee8f6b66ae80c435c.webp",980,1306]